← Home / BIOGEN INC. (BIIB)
Stock Analysis
BIOGEN INC. (BIIB)
BIIB
BIIB · Market data
203.02 -1.44%
Track BIIB in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when BIIB price is:
52W Range Position
86%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-07-20 16:27 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 216.63. Holding above 199.06 keeps the current thesis intact.
⚖️
✓
Fundamentals
Moderate / Positive
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Elevated
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
199.06
↗
Break Above
Confirmation improves above resistance.
216.63
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 199.06
What's Driving BIIB?
📈 Technical recovery is improving
Momentum is Neutral. Watch 216.63 for confirmation and 199.06 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 199.04 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
50.6
◎
How to read this setup
The nearest decision zone is framed by support around 199.04 and resistance near 209.76. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Price Chart
BIIB · WOI overlay chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-17
Fair
Fair valuation
Valuation looks broadly balanced for a mature quality business.
Market Cap
$30.6B
Company size
EV
$34.5B
Debt-adjusted value
P/E
22.3
Reasonable
P/S
3.1
Low sales multiple
P/B
1.6
Low book multiple
EV/Sales
3.5
Low sales multiple
EV/EBIT
12.1
Low multiple
P/FCF
12.6
Low multiple
FCF Yield
7.93%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Improving financial execution
Financial conditions require selective monitoring.
↗
Revenue Growth
Moderate
●
Profitability
Positive
≈
Cash Flow
Healthy
⚖
Balance Sheet
Strong
💵 Revenue
2.48B
≈ Moderate
📈 Net Income
319.50M
↗ Positive
🧮 EPS (Basic)
2.17
↗ Positive
BIOGEN INC.
Related Opportunities